Google Alert - pharmaceutical news

News 9 new results for pharmaceutical news

FDA approves Teva Pharmaceutical's version of Amgen's Neupogen Economic Times ... expensive, than duplicating conventional chemical-based compounds. Generic drugmakers like Israel-based Teva are pushing into the field of biosimilars as global pharmaceutical companies face the loss of patent protection on many established drugs. See all stories on this topic »

Hospira deal to be Rs 7-8 EPS accretive: Orchid Chemicals Moneycontrol.com Hospira deal to be Rs 7-8 EPS accretive: Orchid Chemicals. Shares of Orchid Chemicals were on the rise after the pharmaceutical company sold its penicillin and penem business to US-based Hospira Inc for USD 200 million. Source: CNBC-TV18 ... See all stories on this topic »

Indian drug companies like Glenmark, Dr Reddy's, Sun Pharma break into ... Economic Times MUMBAI: In yet another instance of India Inc occupying a larger seat in the global league tables, three out of the top 10 fastest-growing generic companies globally are now from India . Besides being an indication of the acceptance of domestic ... See all stories on this topic »

"We took an incorrect decision by targeting the wrong market" Hindu Business Line Our research services and methodologies complement our software solutions and enable us to help strengthen the information and analytics needed by pharmaceutical and biotech companies. We use Microsoft, Java and other technologies with service ... See all stories on this topic » Hindu Business Line

Pharmaceutical firm Teva API to set up unit in Indore SEZ; to invest 1000 crore Economic Times INDORE: Pharmaceutical firm Teva API India plans to invest about Rs 1,000 crore over the next five years in setting up of a formulation unit in the Indore special economic zone (SEZ), an official said today. "Teva API is planning to invest about Rs 1 ... See all stories on this topic »

Clearance of Michigan facility by FDA marginally positive for Sun Pharma: Nomura Myiris.com Sun Pharmaceutical Industries, one of the leading durg makers in India, announced on August 28 that the USFDA has allowed its arm Caraco to resume operations at its manufacturing facility and packaging sites in Detriot and Wixom, Michigan following an ... See all stories on this topic »

BioSante Pharmaceuticals, Inc. to Present at Stifel Nicolaus Healthcare ... 4-traders BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, BioSante's president & CEO, will present a corporate update at the Stifel Nicolaus Healthcare Conference and Rodman & Renshaw Global Investment Conferences. See all stories on this topic »

People on the move: outsourcing jobs OutSourcing-Pharma.com Mark Hanley, CEO said: "Now more than ever pharmaceutical companies and contract research organisations (CROs) want to conduct clinical trials that are cost-effective, efficient, and maintain the highest standards for patient safety. "Joanne brings a ... See all stories on this topic » OutSourcing-Pharma.com

Astex Pharmaceuticals to Present at September Investor Conferences Equities.com 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that members of its senior management team will ... See all stories on this topic »

---

Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.